» Articles » PMID: 28027221

Late Surgical-Site Infection in Immediate Implant-Based Breast Reconstruction

Overview
Specialty General Surgery
Date 2016 Dec 28
PMID 28027221
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Surgical-site infection causes devastating reconstructive failure in implant-based breast reconstructions. Large national database studies offer insights into complication rates, but only capture outcomes within 30 days postoperatively. This study evaluates both early and late surgical-site infection in immediate implant-based reconstruction and identifies predictors.

Methods: As part of the Mastectomy Reconstruction Outcomes Consortium Study, 1662 implant-based breast reconstructions in 1024 patients were evaluated for early versus late surgical-site infection. Early surgical-site infection was defined as infection occurring within 30 days postoperatively; late surgical-site infection was defined as infection occurring 31 days to 1 year postoperatively. Minor infection required oral antibiotics only, and major infection required hospitalization and/or surgical treatment. Direct-to-implant patients had 1-year follow-up, and tissue expander patients had 1-year post-exchange follow-up.

Results: Among 1491 tissue expander and 171 direct-to-implant reconstructions, overall surgical-site infection rate for tissue expander was 5.7 percent (85 of 1491) after first-stage, 2.5 percent (31 of 1266) after second-stage, and 9.9 percent (17 of 171) for direct-to-implant reconstruction. Over 47 to 71 percent of surgical-site infection complications were late surgical-site infection. Multivariate analysis identified radiotherapy and increasing body mass index as significant predictors of late surgical-site infection. No significant difference between the direct-to-implant and tissue expander groups in the occurrence of early, late, or overall surgical-site infection was found.

Conclusions: The majority of surgical-site infection complications in immediate implant-based breast reconstructions occur more than 30 days after both first-stage and second-stage procedures. Radiotherapy and obesity are significantly associated with late-onset surgical-site infection. Current studies limited to early complications do not present a complete assessment of infection associated with implant-based breast reconstructions or their long-term clinical outcomes.

Clinical Question/level Of Evidence: Risk, II.

Citing Articles

Conversion from Alloplastic to Autologous Breast Reconstruction: What Are the Inciting Factors?.

Bitoiu B, Schlagintweit S, Zhang Z, Bovill E, Isaac K, Macadam S Plast Surg (Oakv). 2024; 32(2):213-219.

PMID: 38681249 PMC: 11046274. DOI: 10.1177/22925503221107214.


Comorbid Conditions and Complications in Body Contouring Surgery: A Retrospective Review.

Garoosi K, Mundra L, Jabbari K, Winocour J, Iorio M, Mathes D Aesthet Surg J Open Forum. 2023; 5:ojad080.

PMID: 37711766 PMC: 10499002. DOI: 10.1093/asjof/ojad080.


Medical Imaging of Inflammations and Infections of Breast Implants.

Giovannini E, Travascio L, Follacchio G, Bauckneht M, Criscuoli B, De Cataldo C Diagnostics (Basel). 2023; 13(10).

PMID: 37238291 PMC: 10217528. DOI: 10.3390/diagnostics13101807.


Use of Antibiotic-impregnated Polymethylmethacrylate (PMMA) Plates for Prevention of Periprosthetic Infection in Breast Reconstruction.

Johnstone T, Lipman K, Makarewicz N, Shah J, Turner E, Posternak V Plast Reconstr Surg Glob Open. 2023; 11(1):e4764.

PMID: 36776590 PMC: 9911200. DOI: 10.1097/GOX.0000000000004764.


Is Iatrogenic Implant Contamination Preventable Using a 16-Step No-Touch Protocol?.

Singh D, Zhang R, Hori K, Parsa F Eplasty. 2022; 22:e38.

PMID: 36160667 PMC: 9490878.


References
1.
Khavanin N, Gutowski K, Hume K, Simmons C, Mlodinow A, Weiss M . The use of patient registries in breast surgery: a comparison of the tracking operations and outcomes for plastic surgeons and national surgical quality improvement program data sets. Ann Plast Surg. 2015; 74(2):157-62. DOI: 10.1097/SAP.0000000000000383. View

2.
Fischer J, Nelson J, Au A, Tuggle 3rd C, Serletti J, Wu L . Complications and morbidity following breast reconstruction--a review of 16,063 cases from the 2005-2010 NSQIP datasets. J Plast Surg Hand Surg. 2013; 48(2):104-14. DOI: 10.3109/2000656X.2013.819003. View

3.
Momoh A, Ahmed R, Kelley B, Aliu O, Kidwell K, Kozlow J . A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Ann Surg Oncol. 2013; 21(1):118-24. PMC: 4153348. DOI: 10.1245/s10434-013-3284-z. View

4.
Arciola C, Campoccia D, Speziale P, Montanaro L, Costerton J . Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials. 2012; 33(26):5967-82. DOI: 10.1016/j.biomaterials.2012.05.031. View

5.
Nahabedian M, Tsangaris T, Momen B, Manson P . Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003; 112(2):467-76. DOI: 10.1097/01.PRS.0000070727.02992.54. View